Literature DB >> 21862462

Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention.

M Louisa Antoni1, Helèn Boden, Victoria Delgado, Eric Boersma, Kim Fox, Martin J Schalij, Jeroen J Bax.   

Abstract

AIMS: In patients with coronary artery disease, the prognostic value of heart rate has been mainly evaluated in patients with left ventricular dysfunction. Patients with ST-segment elevation acute myocardial infarction (STEMI) are currently treated with primary percutaneous coronary intervention (PCI) and in this contemporary population of patients, the relationship between heart rate and mortality during a follow-up >1 year has not been investigated. METHODS AND
RESULTS: The population comprised 1453 STEMI patients treated with primary PCI. Resting heart rate was measured before discharge and all patients were followed prospectively. MAIN OUTCOME MEASURE: the endpoints were defined as all-cause mortality and cardiovascular mortality. The median follow-up duration was 40 months. During this period, 83(6%) patients died of which 52(4%) died from cardiovascular disease. After adjusting for parameters reflecting a greater infarct size and the presence of heart failure, heart rate at discharge remained a strong predictor of mortality. Patients with a heart rate of ≥70 b.p.m. had a two times increased risk of cardiovascular mortality at 1- and 4-year follow-up compared with patients with a heart rate <70 b.p.m.. In addition, every increase of 5 b.p.m. in heart rate at discharge was associated with a 29 and 24% increased risk of cardiovascular mortality at 1- and 4-year follow-up, respectively.
CONCLUSION: In STEMI patients treated with primary PCI and optimal medical therapy, heart rate at discharge was an important predictor of mortality up to 4 years follow-up even after adjustment for parameters reflecting a greater infarct size and the presence of heart failure.

Entities:  

Mesh:

Year:  2011        PMID: 21862462     DOI: 10.1093/eurheartj/ehr293

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  18 in total

1.  The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction.

Authors:  Eric S Ketchum; Kenneth Dickstein; John Kjekshus; Bertram Pitt; Meagan F Wong; David T Linker; Wayne C Levy
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09-11

2.  Left ventricular apical aneurysm following primary percutaneous coronary intervention.

Authors:  Masayuki Mori; Kenichi Sakakura; Hiroshi Wada; Nahoko Ikeda; Hiroyuki Jinnouchi; Yoshitaka Sugawara; Norifumi Kubo; Shin-ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2012-10-23       Impact factor: 2.037

Review 3.  Interaction between heart rate and heart rate variability.

Authors:  Jerzy Sacha
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-03-06       Impact factor: 1.468

4.  Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.

Authors:  Anna Corletto; Hanna Fröhlich; Tobias Täger; Matthias Hochadel; Ralf Zahn; Caroline Kilkowski; Ralph Winkler; Jochen Senges; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

5.  Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Shao-Li Wang; Cheng-Long Wang; Pei-Li Wang; Hao Xu; Jian-Peng Du; Da-Wu Zhang; Zhu-Ye Gao; Lei Zhang; Chang-Geng Fu; Ke-Ji Chen; Da-Zhuo Shi
Journal:  Exp Biol Med (Maywood)       Date:  2015-11-18

6.  Association between heart rate at rest and myocardial perfusion in patients with acute myocardial infarction undergoing cardiac rehabilitation - a pilot study.

Authors:  Mariko Uematsu; Yoshihiro J Akashi; Kohei Ashikaga; Kihei Yoneyama; Keisuke Kida; Kengo Suzuki; Kazuto Omiya; Tomoo Harada; Maciej Banach; Fumihiko Miyake
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

Review 7.  Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?

Authors:  Ian B A Menown; Simon Davies; Sandeep Gupta; Paul R Kalra; Chim C Lang; Chris Morley; Sandosh Padmanabhan
Journal:  Cardiovasc Ther       Date:  2013-08       Impact factor: 3.023

8.  Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Authors:  Ph Gabriel Steg; Roberto Ferrari; Ian Ford; Nicola Greenlaw; Jean-Claude Tardif; Michal Tendera; Hélène Abergel; Kim M Fox
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

9.  Interplay between heart rate and its variability: a prognostic game.

Authors:  Jerzy Sacha
Journal:  Front Physiol       Date:  2014-09-12       Impact factor: 4.566

10.  Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors.

Authors:  Julius C Heemelaar; Augustinus D G Krol; Marloes Louwerens; Saskia L M A Beeres; Eduard R Holman; Martin J Schalij; M Louisa Antoni
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.